Association for Molecular Pathology v. Myriad Genetics, Inc.
566 U.S. 902, 132 S. Ct. 1794, 182 L. Ed. 2d 613, 80 U.S.L.W. 3545, 2012 WL 986819, 2012 U.S. LEXIS 2356
CourtSupreme Court of the United States
DecidedMarch 26, 2012
DocketNo. 11-725
StatusPublished
Cited by3 cases
This text of 566 U.S. 902 (Association for Molecular Pathology v. Myriad Genetics, Inc.) is published on Counsel Stack Legal Research, covering Supreme Court of the United States primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Bluebook
Association for Molecular Pathology v. Myriad Genetics, Inc., 566 U.S. 902, 132 S. Ct. 1794, 182 L. Ed. 2d 613, 80 U.S.L.W. 3545, 2012 WL 986819, 2012 U.S. LEXIS 2356 (2012).
Opinion
C. A. Fed. Cir. Certiorari granted, judgment vacated, and case remanded for further consideration in light of Mayo Collaborative Services v. Prometheus Laboratories, Inc., ante, p. 66.
Free access — add to your briefcase to read the full text and ask questions with AI
Related
University of Utah Research Foundation v. Ambry Genetics Corp.
774 F.3d 755 (Federal Circuit, 2014)
Association for Molecular Pathology v. United States Patent & Trademark Office
689 F.3d 1303 (Federal Circuit, 2012)
Cite This Page — Counsel Stack
Bluebook (online)
566 U.S. 902, 132 S. Ct. 1794, 182 L. Ed. 2d 613, 80 U.S.L.W. 3545, 2012 WL 986819, 2012 U.S. LEXIS 2356, Counsel Stack Legal Research, https://law.counselstack.com/opinion/association-for-molecular-pathology-v-myriad-genetics-inc-scotus-2012.